Fact CheckerSign in

NCT07417202Recruiting

Intraoperative Wound Irrigation for Pilonidal Disease

Intraoperative Wound Irrigation for Pilonidal Disease: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 26 May 2026

Brief summary (registry, in English)

The purpose of this study is to determine the best method for cleaning wounds during surgery for patients with Stage 3 pilonidal disease. The investigators will compare the standard wound cleaning solution, saline, with a different solution called hypochlorous acid (Vashe, Urgo Medical) to see which one helps wounds heal faster after surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
72 (estimated)
First submitted
10 Feb 2026
Start date
1 Mar 2026
Primary completion date
30 Sept 2028
Lead sponsor
Stanford University
NCT number
NCT07417202

What you commit to

  • Study type: Interventional
  • Planned participants: 72
  • From 1 Mar 2026 to the primary completion date, 30 Sept 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with pilonidal disease that is not classified as stage 3

Other

  • Intellectual disability precluding the patient and/or guardian from being able to consent

Who the study is looking for

  • Stage 3 pilonidal disease according to the Stanford Pilonidal Severity Staging System

Age in the registry: 8 months to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lucile Packard Children's Hospital - Stanford
Coordinator of this site? Confirm its status
Palo AltoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.